Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

2.

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.

Marchesini G, Pasqualetti P, Anichini R, Caputo S, Memoli G, Ponzani P, Resi V, Rizzo M, Serviddio G, Zanette G.

Acta Diabetol. 2019 Mar;56(3):289-299. doi: 10.1007/s00592-018-1236-6. Epub 2018 Oct 10.

PMID:
30306406
3.

High frequency of diabetic ketoacidosis at diagnosis of type 1 diabetes in Italian children: a nationwide longitudinal study, 2004-2013.

Cherubini V, Skrami E, Ferrito L, Zucchini S, Scaramuzza A, Bonfanti R, Buono P, Cardella F, Cauvin V, Chiari G, D Annunzio G, Frongia AP, Iafusco D, Patera IP, Toni S, Tumini S, Rabbone I, Lombardo F, Carle F, Gesuita R; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).

Sci Rep. 2016 Dec 19;6:38844. doi: 10.1038/srep38844.

4.

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.

De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R.

Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183. doi: 10.1038/ctg.2016.42.

5.

The incidence rate and prevalence of pediatric type 1 diabetes mellitus (age 0-18) in the Italian region Friuli Venezia Giulia: population-based estimates through the analysis of health administrative databases.

Valent F, Candido R, Faleschini E, Tonutti L, Tortul C, Zanatta M, Zanette G, Zanier L.

Acta Diabetol. 2016 Aug;53(4):629-35. doi: 10.1007/s00592-016-0854-0. Epub 2016 Mar 21.

PMID:
26997510
6.

Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy.

Gini A, Bidoli E, Zanier L, Clagnan E, Zanette G, Gobbato M, De Paoli P, Serraino D.

Cancer Epidemiol. 2016 Apr;41:80-7. doi: 10.1016/j.canep.2016.01.011. Epub 2016 Feb 3.

PMID:
26851751
7.

Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients.

Fabris M, Zago S, Liguori M, Trevisan MT, Zanatta M, Comici A, Zanette G, Carlin E, Curcio F, Tonutti E.

Auto Immun Highlights. 2015 Aug;6(1-2):17-22. doi: 10.1007/s13317-015-0068-4. Epub 2015 Jul 21.

8.

Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED.

Scaramuzza A, Cherubini V, Tumini S, Bonfanti R, Buono P, Cardella F, d'Annunzio G, Frongia AP, Lombardo F, Monciotti AC, Rabbone I, Schiaffini R, Toni S, Zucchini S, Frontino G, Iafusco D; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology.

Acta Diabetol. 2014 Apr;51(2):173-84. doi: 10.1007/s00592-013-0521-7. Epub 2013 Oct 27. Review.

PMID:
24162715
9.

Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Balbi M, Donadon V, Ghersetti M, Grazioli S, Valentina GD, Gardenal R, Mas MD, Casarin P, Zanette G, Miranda C, Cimarosti P.

Int J Environ Res Public Health. 2010 Apr;7(4):1366-78. doi: 10.3390/ijerph7041366. Epub 2010 Mar 29.

10.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.

Donadon V, Balbi M, Mas MD, Casarin P, Zanette G.

Liver Int. 2010 May;30(5):750-8. doi: 10.1111/j.1478-3231.2010.02223.x. Epub 2010 Mar 12.

PMID:
20331505
11.

Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.

Donadon V, Balbi M, Zanette G.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):465-7. doi: 10.1586/egh.09.41. No abstract available.

PMID:
19817667
12.

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.

Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, Gardenal R, Dal Mas M, Casarin P, Zanette G, Miranda C.

World J Gastroenterol. 2009 May 28;15(20):2506-11.

13.

Type 2 diabetes mellitus and increased prevalence of hepatocarcinoma in HIV-infected population.

Perciaccante A, Zanette G, Donadon V.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):573. doi: 10.1097/QAI.0b013e31818d5fb6. No abstract available.

PMID:
19202464
14.

KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.

Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crinó A, Lorini R, Cerutti F, Vanelli M, Barbetti F; Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.

Hum Mutat. 2005 Jan;25(1):22-7.

PMID:
15580558

Supplemental Content

Loading ...
Support Center